Literature DB >> 3597703

Circulating luteinizing hormone pulse frequency in women with polycystic ovary syndrome.

R R Kazer, B Kessel, S S Yen.   

Abstract

To determine whether pulsatile LH frequency is altered in patients with the polycystic ovary syndrome (PCO) serum LH was measured every 10 min for 12 h (0800-2000 h) in nine patients. Six cycling women studied in the midfollicular (MF) or early follicular (EF) phases of their cycle served as controls. Three of these women were studied in both phases, yielding a total of nine control studies. In the PCO patients the mean LH pulse frequency was 12.1 +/- 0.7 (+/- SE) pulses/12 h. This value was indistinguishable from that of normal EF (12.1 +/- 0.4 pulses/12 h) or MF women (12.0 +/- 0.7 pulses/12 h). In contrast, the mean LH pulse amplitude in the PCO patients (12.2 +/- 2.7 mIU/mL) was higher (P less than 0.05) than that in normal women in either phase (EF, 6.2 +/- 0.8 mIU/mL; MF, 6.4 +/- 0.6 mIU/mL). These results suggest that the elevations in serum LH levels that occur in PCO patients are due primarily to increased LH pulse amplitude rather than increased pulse frequency.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3597703     DOI: 10.1210/jcem-65-2-233

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

1.  Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women.

Authors:  P Fioretti; A Cagnacci; A M Paoletti; M Gambacciani; R Soldani; G A Mauro; A Spinetti; G B Melis
Journal:  J Endocrinol Invest       Date:  1989-05       Impact factor: 4.256

Review 2.  Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity.

Authors:  Robert L Rosenfield; Brian Bordini
Journal:  Brain Res       Date:  2010-09-25       Impact factor: 3.252

Review 3.  Hypersecretion of luteinizing hormone in the polycystic ovary syndrome and a novel hormone 'gonadotrophin surge attenuating factor'.

Authors:  A H Balen
Journal:  J R Soc Med       Date:  1995-06       Impact factor: 5.344

Review 4.  The regulation of reproductive neuroendocrine function by insulin and insulin-like growth factor-1 (IGF-1).

Authors:  Andrew Wolfe; Sara Divall; Sheng Wu
Journal:  Front Neuroendocrinol       Date:  2014-06-12       Impact factor: 8.606

Review 5.  Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.

Authors:  Daniel A Dumesic; Sharon E Oberfield; Elisabet Stener-Victorin; John C Marshall; Joop S Laven; Richard S Legro
Journal:  Endocr Rev       Date:  2015-10       Impact factor: 19.871

6.  Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective study.

Authors:  A M Fulghesu; M Ciampelli; C Belosi; R Apa; M Guido; A Caruso; S Mancuso; A Lanzone
Journal:  J Endocrinol Invest       Date:  2001 Jul-Aug       Impact factor: 4.256

7.  A factor analysis approach to examining relationships among ovarian steroid concentrations, gonadotrophin concentrations and menstrual cycle length characteristics in healthy, cycling women.

Authors:  E S Barrett; I Thune; S F Lipson; A-S Furberg; P T Ellison
Journal:  Hum Reprod       Date:  2012-12-18       Impact factor: 6.918

8.  Luteinizing hormone pulsatility in patients with major ovarian hyperandrogenism.

Authors:  A Bachelot; K Laborde; J L Bresson; G Plu-Bureau; A Raynaud; X Bertagna; A Mogenet; M Mansour; V Lucas-Jouy; J-P Gayno; Y Reznik; J-M Kuhn; L Billaud; M-C Vacher-Lavenu; M Putterman; I Mowszowicz; P Touraine; F Kuttenn
Journal:  J Endocrinol Invest       Date:  2007-09       Impact factor: 4.256

Review 9.  Role of GnRH drive in the pathophysiology of polycystic ovary syndrome.

Authors:  M P Leondires; S L Berga
Journal:  J Endocrinol Invest       Date:  1998 Jul-Aug       Impact factor: 4.256

10.  Effects of hyperandrogenemia and increased adiposity on reproductive and metabolic parameters in young adult female monkeys.

Authors:  W K McGee; C V Bishop; C R Pohl; R J Chang; J C Marshall; F K Pau; R L Stouffer; J L Cameron
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-04-15       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.